Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16837862
[patent_doc_number] => 20210145874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => SUPERNATANT FROM A COCULTURE OF MACROPHAGES AND IRRADIATED LEUKOCYTES, FOR CONTROLLING TUMOUR PROGRESSION OR RESTORING ANTI-TUMOR IMMUNITY
[patent_app_type] => utility
[patent_app_number] => 17/252818
[patent_app_country] => US
[patent_app_date] => 2019-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2358
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17252818
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/252818 | SUPERNATANT FROM A COCULTURE OF MACROPHAGES AND IRRADIATED LEUKOCYTES, FOR CONTROLLING TUMOUR PROGRESSION OR RESTORING ANTI-TUMOR IMMUNITY | Jun 19, 2019 | Pending |
Array
(
[id] => 14991077
[patent_doc_number] => 20190314496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => POLYMERIC CARRIER CARGO COMPLEX FOR USE AS AN IMMUNOSTIMULATING AGENT OR AS AN ADJUVANT
[patent_app_type] => utility
[patent_app_number] => 16/445134
[patent_app_country] => US
[patent_app_date] => 2019-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52628
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -56
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16445134
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/445134 | Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant | Jun 17, 2019 | Issued |
Array
(
[id] => 17679971
[patent_doc_number] => 11364201
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-21
[patent_title] => Nano-liposome carrier composition containing hybrid of Cas9 protein and guide RNA
[patent_app_type] => utility
[patent_app_number] => 16/438539
[patent_app_country] => US
[patent_app_date] => 2019-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 25
[patent_no_of_words] => 8683
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16438539
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/438539 | Nano-liposome carrier composition containing hybrid of Cas9 protein and guide RNA | Jun 11, 2019 | Issued |
Array
(
[id] => 17541213
[patent_doc_number] => 11306326
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-19
[patent_title] => Biologically active synthetic nanoparticle constructs and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/437898
[patent_app_country] => US
[patent_app_date] => 2019-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 22
[patent_no_of_words] => 10096
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16437898
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/437898 | Biologically active synthetic nanoparticle constructs and methods of use thereof | Jun 10, 2019 | Issued |
Array
(
[id] => 15175309
[patent_doc_number] => 20190358246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => Metakaryocidal Treatments
[patent_app_type] => utility
[patent_app_number] => 16/430768
[patent_app_country] => US
[patent_app_date] => 2019-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10599
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16430768
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/430768 | Metakaryocidal Treatments | Jun 3, 2019 | Abandoned |
Array
(
[id] => 17741459
[patent_doc_number] => 11389504
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => Methods of using ZSCAN4 for rejuvenating human cells
[patent_app_type] => utility
[patent_app_number] => 16/427038
[patent_app_country] => US
[patent_app_date] => 2019-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 35
[patent_no_of_words] => 54424
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16427038
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/427038 | Methods of using ZSCAN4 for rejuvenating human cells | May 29, 2019 | Issued |
Array
(
[id] => 14864837
[patent_doc_number] => 20190282660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => METHODS OF USING ZSCAN4 FOR REJUVENATING HUMAN CELLS
[patent_app_type] => utility
[patent_app_number] => 16/427097
[patent_app_country] => US
[patent_app_date] => 2019-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54419
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16427097
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/427097 | METHODS OF USING ZSCAN4 FOR REJUVENATING HUMAN CELLS | May 29, 2019 | Abandoned |
Array
(
[id] => 16932803
[patent_doc_number] => 20210198692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => ADENO-ASSOCIATED VIRAL VECTOR-MEDIATED GENE THERAPY FOR TREATING FRAGILE X-ASSOCIATED DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/057346
[patent_app_country] => US
[patent_app_date] => 2019-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8526
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17057346
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/057346 | ADENO-ASSOCIATED VIRAL VECTOR-MEDIATED GENE THERAPY FOR TREATING FRAGILE X-ASSOCIATED DISORDERS | May 29, 2019 | Pending |
Array
(
[id] => 14868585
[patent_doc_number] => 20190284534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => ENCAPSULATION AND CARDIAC DIFFERENTIATION OF HIPSCS IN 3D PEG-FIBRINOGEN HYDROGELS
[patent_app_type] => utility
[patent_app_number] => 16/420714
[patent_app_country] => US
[patent_app_date] => 2019-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14933
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16420714
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/420714 | Encapsulation and cardiac differentiation of hiPSCs in 3D PEG-fibrinogen hydrogels | May 22, 2019 | Issued |
Array
(
[id] => 16806083
[patent_doc_number] => 20210128636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => FIBROBLAST DELIVERY OF TUMOR INHIBITORY AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/052830
[patent_app_country] => US
[patent_app_date] => 2019-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14124
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17052830
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/052830 | FIBROBLAST DELIVERY OF TUMOR INHIBITORY AGENTS | May 2, 2019 | Pending |
Array
(
[id] => 14743589
[patent_doc_number] => 20190254968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => OIL-IN-WATER EMULSIONS THAT CONTAIN NUCLEIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 16/401452
[patent_app_country] => US
[patent_app_date] => 2019-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28548
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16401452
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/401452 | Oil-in-water emulsions that contain nucleic acids | May 1, 2019 | Issued |
Array
(
[id] => 15264919
[patent_doc_number] => 20190381193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => RNA FOR USE IN THE TREATMENT OF LIGAMENT OR TENDON LESIONS
[patent_app_type] => utility
[patent_app_number] => 16/398191
[patent_app_country] => US
[patent_app_date] => 2019-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18767
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16398191
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/398191 | RNA for use in the treatment of ligament or tendon lesions | Apr 28, 2019 | Issued |
Array
(
[id] => 14960663
[patent_doc_number] => 20190307809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => METHODS AND COMPOSITIONS FOR IN VIVO INDUCTION OF PANCREATIC BETA CELL FORMATION
[patent_app_type] => utility
[patent_app_number] => 16/394312
[patent_app_country] => US
[patent_app_date] => 2019-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17724
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16394312
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/394312 | Methods and compositions for in vivo induction of pancreatic beta cell formation | Apr 24, 2019 | Issued |
Array
(
[id] => 15114269
[patent_doc_number] => 20190343767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => ARTIFICIAL EXOSOME COMPOSITION AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 16/393582
[patent_app_country] => US
[patent_app_date] => 2019-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20881
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16393582
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/393582 | Artificial exosome composition and related methods | Apr 23, 2019 | Issued |
Array
(
[id] => 15797599
[patent_doc_number] => 20200121942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => COMPOSITIONS AND METHODS FOR CONTROLLING PAIN
[patent_app_type] => utility
[patent_app_number] => 16/388456
[patent_app_country] => US
[patent_app_date] => 2019-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28270
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16388456
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/388456 | COMPOSITIONS AND METHODS FOR CONTROLLING PAIN | Apr 17, 2019 | Abandoned |
Array
(
[id] => 15338979
[patent_doc_number] => 10525146
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-07
[patent_title] => Metal oxide nanoparticle for cell lysis
[patent_app_type] => utility
[patent_app_number] => 16/385519
[patent_app_country] => US
[patent_app_date] => 2019-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 25
[patent_no_of_words] => 12941
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16385519
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/385519 | Metal oxide nanoparticle for cell lysis | Apr 15, 2019 | Issued |
Array
(
[id] => 14806381
[patent_doc_number] => 20190269800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => IMMUNOADSORPTION
[patent_app_type] => utility
[patent_app_number] => 16/384602
[patent_app_country] => US
[patent_app_date] => 2019-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14092
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16384602
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/384602 | Immunoadsorption | Apr 14, 2019 | Issued |
Array
(
[id] => 14990945
[patent_doc_number] => 20190314430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OF AUTOSOMAL RECESSIVE CONGENITAL ICHTHYOSIS
[patent_app_type] => utility
[patent_app_number] => 16/381557
[patent_app_country] => US
[patent_app_date] => 2019-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33301
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16381557
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/381557 | Compositions and methods for the treatment of autosomal recessive congenital ichthyosis | Apr 10, 2019 | Issued |
Array
(
[id] => 17525720
[patent_doc_number] => 11298386
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-12
[patent_title] => Drug composition for angiogenesis therapy
[patent_app_type] => utility
[patent_app_number] => 16/373388
[patent_app_country] => US
[patent_app_date] => 2019-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6308
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16373388
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/373388 | Drug composition for angiogenesis therapy | Apr 1, 2019 | Issued |
Array
(
[id] => 14621515
[patent_doc_number] => 20190224125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => LIPOSOMAL COMPOSITIONS AND USES OF SAME
[patent_app_type] => utility
[patent_app_number] => 16/372449
[patent_app_country] => US
[patent_app_date] => 2019-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24040
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16372449
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/372449 | Liposomal compositions and uses of same | Apr 1, 2019 | Issued |